Back to News
Market Impact: 0.35
J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff
Source: Bloomberg
Corporate EarningsHealthcare & BiotechM&A & RestructuringAnalyst Estimates
Johnson & Johnson's medical technology sales rose 2.5% but missed estimates. The company is leaning toward spinning off its orthopedics business; no timing or financial terms were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
JNJ-0.45
More News
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- Meta shares rise for a second straight day as new AI model family impresses
- J&J beats earnings estimates; Middle East conflict weighs on medical-device sales
- Wall St edges lower as chips fall; markets assess big bank earnings
- Wall Street Banks Face New Pressure
- Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast